Clinical Impact of the CYP2C19 Gene on Diazepam for the Management of Alcohol Withdrawal Syndrome

Diazepam is a benzodiazepine widely prescribed for the management of patients with severe alcohol withdrawal syndrome to prevent agitation, withdrawal seizures, and delirium tremens. Despite standard dosing of diazepam, a subset of patients experience refractory withdrawal syndromes or adverse drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Ho, Teresa T., Noble, Melissa, Tran, Bao Anh, Sunjic, Katlynd, Gupta, Sheeba Varghese, Turgeon, Jacques, Crutchley, Rustin D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961427/
https://www.ncbi.nlm.nih.gov/pubmed/36836519
http://dx.doi.org/10.3390/jpm13020285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961427/
https://www.ncbi.nlm.nih.gov/pubmed/36836519
http://dx.doi.org/10.3390/jpm13020285

Ejemplares similares